Literature DB >> 15870203

Specific correlation between the wobble modification deficiency in mutant tRNAs and the clinical features of a human mitochondrial disease.

Yohei Kirino1, Yu-Ichi Goto, Yolanda Campos, Joaquin Arenas, Tsutomu Suzuki.   

Abstract

Mutations in mtDNA are responsible for a variety of mitochondrial diseases, where the mitochondrial tRNA(Leu(UUR)) gene has especially hot spots for pathogenic mutations. Clinical features often depend on the tRNA species and/or positions of the mutations; however, molecular pathogenesis elucidating the relation between the location of the mutations and their leading phenotype are not fully understood. We report here that mitochondrial tRNAs(Leu(UUR)) harboring one of five mutations found in tissues from patients with symptoms of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) (A3243G, G3244A, T3258C, T3271C, and T3291C) lacked the normal taurine-containing modification (5-taurinomethyluridine) at the anticodon wobble position. In contrast, mitochondrial tRNAs(Leu(UUR)) with different mutations found in patients that have mitochondrial diseases but do not show the MELAS symptoms (G3242A, T3250C, C3254T, and A3280G) had the normal 5-taurinomethyluridine modifications. These observations were made by using a modified primer extension technique that can detect the modification deficiency in the extremely limited quantities of mutant tRNAs obtainable from patient tissues. These results strongly suggest deficient wobble modification could be a key molecular factor responsible for the phenotypic features of MELAS, which can explain why the different MELAS-associated mutations result in indistinguishable clinical features.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15870203      PMCID: PMC1129107          DOI: 10.1073/pnas.0500563102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation.

Authors:  Y Goto; S Horai; T Matsuoka; Y Koga; K Nihei; M Kobayashi; I Nonaka
Journal:  Neurology       Date:  1992-03       Impact factor: 9.910

2.  Impairment of mitochondrial transcription termination by a point mutation associated with the MELAS subgroup of mitochondrial encephalomyopathies.

Authors:  J F Hess; M A Parisi; J L Bennett; D A Clayton
Journal:  Nature       Date:  1991-05-16       Impact factor: 49.962

3.  A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS).

Authors:  Y Goto; I Nonaka; S Horai
Journal:  Biochim Biophys Acta       Date:  1991-10-21

4.  Accumulation of mtDNA with a mutation at position 3271 in tRNA(Leu)(UUR) gene introduced from a MELAS patient to HeLa cells lacking mtDNA results in progressive inhibition of mitochondrial respiratory function.

Authors:  J Hayashi; S Ohta; D Takai; S Miyabayashi; R Sakuta; Y Goto; I Nonaka
Journal:  Biochem Biophys Res Commun       Date:  1993-12-30       Impact factor: 3.575

5.  Mitochondrial DNA mutations at nucleotide positions 3243 and 3271 in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes: a comparative study.

Authors:  R Sakuta; Y Goto; S Horai; I Nonaka
Journal:  J Neurol Sci       Date:  1993-04       Impact factor: 3.181

Review 6.  Classical and novel approaches to the detection and localization of the numerous modified nucleotides in eukaryotic ribosomal RNA.

Authors:  B E Maden; M E Corbett; P A Heeney; K Pugh; P M Ajuh
Journal:  Biochimie       Date:  1995       Impact factor: 4.079

7.  Complex I deficiency is associated with 3243G:C mitochondrial DNA in osteosarcoma cell cybrids.

Authors:  D R Dunbar; P A Moonie; M Zeviani; I J Holt
Journal:  Hum Mol Genet       Date:  1996-01       Impact factor: 6.150

8.  A novel point mutation in the mitochondrial tRNA(Leu)(UUR) gene in a family with mitochondrial myopathy.

Authors:  Y Goto; M Tojo; J Tohyama; S Horai; I Nonaka
Journal:  Ann Neurol       Date:  1992-06       Impact factor: 10.422

9.  A new point mutation at nucleotide pair 3291 of the mitochondrial tRNA(Leu(UUR)) gene in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS).

Authors:  Y Goto; K Tsugane; Y Tanabe; I Nonaka; S Horai
Journal:  Biochem Biophys Res Commun       Date:  1994-08-15       Impact factor: 3.575

10.  MELAS mutation in mtDNA binding site for transcription termination factor causes defects in protein synthesis and in respiration but no change in levels of upstream and downstream mature transcripts.

Authors:  A Chomyn; A Martinuzzi; M Yoneda; A Daga; O Hurko; D Johns; S T Lai; I Nonaka; C Angelini; G Attardi
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

View more
  68 in total

1.  Biosynthesis of wybutosine, a hyper-modified nucleoside in eukaryotic phenylalanine tRNA.

Authors:  Akiko Noma; Yohei Kirino; Yoshiho Ikeuchi; Tsutomu Suzuki
Journal:  EMBO J       Date:  2006-04-27       Impact factor: 11.598

Review 2.  Codon-biased translation can be regulated by wobble-base tRNA modification systems during cellular stress responses.

Authors:  Lauren Endres; Peter C Dedon; Thomas J Begley
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

3.  Trmt61B is a methyltransferase responsible for 1-methyladenosine at position 58 of human mitochondrial tRNAs.

Authors:  Takeshi Chujo; Tsutomu Suzuki
Journal:  RNA       Date:  2012-10-24       Impact factor: 4.942

4.  Pathogenic mechanism of a human mitochondrial tRNAPhe mutation associated with myoclonic epilepsy with ragged red fibers syndrome.

Authors:  Jiqiang Ling; Hervé Roy; Daoming Qin; Mary Anne T Rubio; Juan D Alfonzo; Kurt Fredrick; Michael Ibba
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

5.  Characterization of human GTPBP3, a GTP-binding protein involved in mitochondrial tRNA modification.

Authors:  Magda Villarroya; Silvia Prado; Juan M Esteve; Miguel A Soriano; Carmen Aguado; David Pérez-Martínez; José I Martínez-Ferrandis; Lucía Yim; Victor M Victor; Elvira Cebolla; Asunción Montaner; Erwin Knecht; M-Eugenia Armengod
Journal:  Mol Cell Biol       Date:  2008-10-13       Impact factor: 4.272

6.  Oxidative stress and dysregulation of the taurine transporter in high-glucose-exposed human Schwann cells: implications for pathogenesis of diabetic neuropathy.

Authors:  Trevor Askwith; Wei Zeng; Margaret C Eggo; Martin J Stevens
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-07-14       Impact factor: 4.310

Review 7.  Physiological roles of taurine in heart and muscle.

Authors:  Stephen W Schaffer; Chian Ju Jong; K C Ramila; Junichi Azuma
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

8.  Effect of beta-alanine treatment on mitochondrial taurine level and 5-taurinomethyluridine content.

Authors:  Chian Ju Jong; Takashi Ito; Mahmood Mozaffari; Junichi Azuma; Stephen Schaffer
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

9.  A novel mitochondrial tRNA(Val) T1658C mutation identified in a CPEO family.

Authors:  Naihong Yan; Shuping Cai; Bo Guo; Yi Mou; Jing Zhu; Jun Chen; Ting Zhang; Ronghua Li; Xuyang Liu
Journal:  Mol Vis       Date:  2010-08-25       Impact factor: 2.367

10.  The m.3244G>A mutation in mtDNA is another cause of progressive external ophthalmoplegia.

Authors:  Evangelia Sotiriou; Jorida Coku; Kurenai Tanji; Hua-bin Huang; Michio Hirano; Salvatore DiMauro
Journal:  Neuromuscul Disord       Date:  2009-03-13       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.